株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

神経変調療法装置市場:世界の産業規模・市場シェア・動向・分析・予測

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018

発行 Transparency Market Research 商品コード 253514
出版日 ページ情報 英文 125 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
神経変調療法装置市場:世界の産業規模・市場シェア・動向・分析・予測 Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018
出版日: 2012年10月30日 ページ情報: 英文 125 Pages
概要

当レポートでは、世界の神経変調療法用装置市場について調査し、市場規模の実績と予測、技術セグメント・アプリケーション分野・地域別の分析、、競合分析および主要企業のプロファイルなどをまとめ、概略以下の構成でお届けします。

第1章 序文

第2章 エグゼクティブサマリー・市場概要

第3章 市場分析

  • 市場動向・将来の展望
  • 市場シェア
  • 市場促進因子
  • 神経変調療法装置の市場促進因子の影響分析
  • 市場阻害因子
  • 神経変調療法装置の市場阻害因子の影響分析
  • 機会
  • 神経変調療法装置の機会の影響分析
  • 原材料の動向
  • ポーターのファイブフォースモデル

第4章 神経変調療法装置市場:技術別

  • 脊髄電気刺激装置
  • 脳深部電気刺激装置
  • 迷走神経刺激装置
  • 仙骨神経刺激装置
  • 胃電気刺激装置

第5章 アプリケーション分野別の神経変調療法装置

  • Medtronic:Spinal Cord and Deep Brain Neurostimulation Systems
  • St. Jude Medical:Eon Mini Neurostimulator System
  • Boston Scientific:Precision Spinal Cord Stimulation System
  • Nevro:Senza System for Spinal Cord Stimulation
  • Cyberonics:VNS Therapy System
  • Codman & Shurtleff:Medstream system
  • Medtronic:Enterra Therapy System
  • IntraPace:abiliti system

第6章 神経変調療法装置市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 競合情勢

  • サマリー
  • 市場シェア:主要企業別
  • 新規参入企業/市場参入企業
  • 競合戦略:主要企業別
  • 近年の発展

第8章 提案

  • 成功のための市場戦略
  • 考えられる障壁
  • 将来の予測

第9章 企業プロファイル

  • 既存企業
    • Medtronic
    • St. Jude Medical
    • Boston Scientific
    • Cyberonics
    • Nevro
  • 新規参入企業
    • Johnson & Johnson (Codman and Shurtleff)
    • Integra
    • IntraPace
    • Neuronetics, Inc.
    • Cervel Neurotech, Inc.
    • Uroplasty

図表リスト

目次

This report covers an in depth analysis of the neuromodulation devices market across the globe. A detailed analysis of the market size in terms of annual revenue in USD millions is provided for the period 2012 to 2018, keeping 2011 as a base year. The neuromodulation devices market is segmented on the basis of technology into: Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices and Gastric Electric Stimulation Devices.

The neuromodulation devices market is also segmented on the basis of different application areas into: Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems, St. Jude Medical's Eon Mini Neurostimulator System, Boston Scientific's Precision Spinal Cord Stimulation System, Nevro's Senza System for Spinal Cord Stimulation, Cyberonics' VNS Therapy System, Codman & Shurtleff's Medstream system, Medtronic's Enterra Therapy System and IntraPace's abiliti system. The market analysis for all these segments is provided on a geographical level and this report covers four major geographies namely: North America, Europe, Asia Pacific and the rest of the world.

In this research report Transparency Market Research covers an in depth competitive analysis for the market, taking into consideration some of the major market players. The market players considered are: Medtronic, St. Jude Medical, Boston Scientific Group, Cyberonics, Nevro, Codman and Shurtleff, Integra, IntraPace, Neuronetics Inc., Cervel Neurotech Inc. and Uroplasty. A detailed analysis of their business strategies, company overview, financial overview, product portfolio SWOT Analysis and recent developments is also provided in the report.

We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the neuromodulation devices market through means of primary research to finally come up with our results. This research is specially designed to estimate and analyze the performance of neuromodulation devices in a global scenario. This research provides in-depth analysis of the neuromodulation devices market sales, trend analysis by segments and demand by geography. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global neuromodulation devices market as below:

Neuromodulation Devices Market by Technology

  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices

Neuromodulation Systems for Different Application Areas

  • Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems
  • St. Jude Medical's Eon Mini Neurostimulator System
  • Boston Scientific's Precision Spinal Cord Stimulation System
  • Nevro's Senza System for Spinal Cord Stimulation
  • Cyberonics' VNS Therapy System
  • Codman & Shurtleff's Medstream system
  • Medtronic's Enterra™ Therapy System
  • IntraPace's abiliti system

Neuromodulation Devices Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • RoW (Rest of the World)

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methodology

2. Executive Summary and Market Overview

3. Neuromodulation Devices Market Analysis

  • 3.1. Market Trends and Future Outlook
  • 3.2. Market Share
  • 3.3. Growth Drivers
    • 3.3.1. Aging population inducing chronic diseases such as Parkinson's and Alzheimer's
    • 3.3.2. Technological advancements
    • 3.3.3. Rising prevalence of chronic diseases and the presence of unmet medical needs
    • 3.3.4. Add on therapy nature of the Neuromodulation devices
    • 3.3.5. Increasing demand for minimally invasive surgeries
    • 3.3.6. Rising healthcare related consumer expenditure
    • 3.3.7. External funding to conduct clinical studies
  • 3.4. Neuromodulation Devices Drivers Impact Analysis
  • 3.5. Restraints
    • 3.5.1. Side effects and risks of Neuromodulation
    • 3.5.2. FDA approvals and other government regulations
    • 3.5.3. Rapidly changing technologies
    • 3.5.4. Affordable Healthcare for America Act, 2010
    • 3.5.5. Availability of alternate treatment procedures
  • 3.6. Neuromodulation Devices Restraints Impact Analysis
  • 3.7. Opportunities
    • 3.7.1. Emerging economies in Asia, Latin America and Eastern European countries
    • 3.7.2. Medical device manufacture outsourcing
    • 3.7.3. Investments in R&D and clinical studies
    • 3.7.4. Consolidation in healthcare industry
  • 3.8. Opportunity Impact Analysis for the Neuromodulation Devices Market
  • 3.9. Porter's Five Forces Model for the Neuromodulation Devices Market

4. Neuromodulation Devices Market by Technology

  • 4.1. Spinal Cord Stimulation Devices
    • 4.1.1. Overview
    • 4.1.2. Market Estimate and Forecast
  • 4.2. Deep Brain Stimulation Devices
    • 4.2.1. Overview
    • 4.2.2. Market Estimate and Forecast
  • 4.3. Vagus Nerve Stimulation Devices
    • 4.3.1. Overview
    • 4.3.2. Market Estimate and Forecast
  • 4.4. Sacral Nerve Stimulation Devices
    • 4.4.1. Overview
    • 4.4.2. Market Estimate and Forecast
  • 4.5. Gastric Electric Stimulation Devices
    • 4.5.1. Overview
    • 4.5.2. Market Estimate and Forecast

5. Neuromodulation Systems for Different Application Areas

  • 5.1. Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems
    • 5.1.1. Application Overview
    • 5.1.2. Market Estimate and Forecast
  • 5.2. St. Jude Medical's Eon Mini Neurostimulator System
    • 5.2.1. Application Overview
    • 5.2.2. Market Estimate and Forecast
  • 5.3. Boston Scientific's Precision Spinal Cord Stimulation System
    • 5.3.1. Application Overview
    • 5.3.2. Market Estimate and Forecast
  • 5.4. Nevro's Senza System for Spinal Cord Stimulation
    • 5.4.1. Application Overview
    • 5.4.2. Market Estimate and Forecast
  • 5.5. Cyberonics' VNS Therapy System
    • 5.5.1. Application Overview
    • 5.5.2. Market Estimate and Forecast
  • 5.6. Codman & Shurtleff's Medstream system
    • 5.6.1. Application Overview
    • 5.6.2. Market Estimate and Forecast
  • 5.7. Medtronic's Enterra™ Therapy System
    • 5.7.1. Application Overview
    • 5.7.2. Market Estimate and Forecast
  • 5.8. IntraPace's abiliti system
    • 5.8.1. Application Overview
    • 5.8.2. Market Estimate and Forecast

6. Neuromodulation Devices Market by Geography

  • 6.1. North America
    • 6.1.1. Overview
    • 6.1.2. Market Estimate and Forecast
  • 6.2. Europe
    • 6.2.1. Overview
    • 6.2.2. Market Estimate and Forecast
  • 6.3. Asia Pacific
    • 6.3.1. Overview
    • 6.3.2. Market Estimate and Forecast
  • 6.4. Rest of the World
    • 6.4.1. Overview
    • 6.4.2. Market Estimate and Forecast

7. Competitive Landscape

  • 7.1. Summary
  • 7.2. Market share by Key Players
  • 7.3. New Entrants/Market Players
  • 7.4. Competitive strategy by Key Players
    • 7.4.1. Market Leaders
    • 7.4.2. New Entrants
  • 7.5. Recent Developments

8. Recommendations

  • 8.1. Market Strategy for Success
  • 8.2. Barriers to be Considered
  • 8.3. Future Assumptions

9. Company Profiles

  • 9.1. Existent Players
    • 9.1.1. Medtronic
      • 9.1.1.1. Company Overview
      • 9.1.1.2. Business Strategies
      • 9.1.1.3. Financial Overview
      • 9.1.1.4. Product Portfolio
      • 9.1.1.5. SWOT Analysis
      • 9.1.1.6. Recent Developments
    • 9.1.2. St. Jude Medical
      • 9.1.2.1. Company Overview
      • 9.1.2.2. Business Strategies
      • 9.1.2.3. Financial Overview
      • 9.1.2.4. Product Portfolio
      • 9.1.2.5. SWOT Analysis
      • 9.1.2.6. Recent Developments
    • 9.1.3. Boston Scientific
      • 9.1.3.1. Company Overview
      • 9.1.3.2. Business Strategies
      • 9.1.3.3. Financial Overview
      • 9.1.3.4. Product Portfolio
      • 9.1.3.5. SWOT Analysis
      • 9.1.3.6. Recent Developments
    • 9.1.4. Cyberonics
      • 9.1.4.1. Company Overview
      • 9.1.4.2. Business Strategies
      • 9.1.4.3. Financial Overview
      • 9.1.4.4. Product Portfolio
      • 9.1.4.5. SWOT Analysis
      • 9.1.4.6. Recent Developments
    • 9.1.5. Nevro
      • 9.1.5.1. Company Overview
      • 9.1.5.2. Business Strategies
      • 9.1.5.3. Financial Overview
      • 9.1.5.4. Product Portfolio
      • 9.1.5.5. Recent Developments
  • 9.2. New Entrants
    • 9.2.1. Johnson & Johnson (Codman and Shurtleff)
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Business Strategies
      • 9.2.1.3. Financial Overview
      • 9.2.1.4. Product Portfolio
      • 9.2.1.5. SWOT Analysis
      • 9.2.1.6. Recent Developments
    • 9.2.2. Integra
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Business Strategies
      • 9.2.2.3. Financial Overview
      • 9.2.2.4. Product Portfolio
      • 9.2.2.5. Recent Developments
    • 9.2.3. IntraPace
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Business Strategies
      • 9.2.3.3. Financial Overview
      • 9.2.3.4. Product Portfolio
      • 9.2.3.5. Recent Developments
    • 9.2.4. Neuronetics, Inc.
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Business Strategies
      • 9.2.4.3. Financial Overview
      • 9.2.4.4. Product Portfolio
      • 9.2.4.5. Recent Developments
    • 9.2.5. Cervel Neurotech, Inc.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Business Strategies
      • 9.2.5.3. Financial Overview
      • 9.2.5.4. Product Portfolio
      • 9.2.5.5. Recent Developments
    • 9.2.6. Uroplasty
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Business Strategies
      • 9.2.6.3. Financial Overview
      • 9.2.6.4. Product Portfolio
      • 9.2.6.5. Recent Developments
Back to Top